SCHEMBL21625073

SCHEMBL21625073

CN(C)CCNC(=O)c1nn(-c2ccccc2)c2c1CCc1sccc1-2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SHMT2 P34897 2/20 0.48
▸ RAD52 P43351 1/20 0.45
▸ POLB P06746 1/20 0.44
▸ KIF11 P52732 1/20 0.40
▸ PIK3CD O00329 1/20 0.39
▸ PIK3R2 O00459 1/20 0.39
▸ PIK3CA P42336 1/20 0.39
▸ PIK3CB P42338 1/20 0.39
▸ PIK3CG P48736 1/20 0.39
▸ PIK3R5 Q8WYR1 1/20 0.39
▸ PIK3R3 Q92569 1/20 0.39
▸ CCNA2 P20248 2/20 0.39
▸ CDK2 P24941 2/20 0.39
▸ CCNA1 P78396 2/20 0.39
▸ MAPT P10636 3/20 0.38
▸ THRB P10828 1/20 0.38
▸ TP53 P04637 3/20 0.38
▸ NFKB1 P19838 1/20 0.38
▸ NFKB2 Q00653 1/20 0.38
▸ RELA Q04206 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21625120 0.88 SHMT2 (0.43) SHMT2RAD52POLBPIK3CDPIK3R2
SCHEMBL21625114 0.87 CDK2 (0.43) SHMT2RAD52PIK3CDPIK3R2PIK3CA
SCHEMBL21625146 0.82 CACNA2D1 (0.41) SHMT2RAD52PIK3CDPIK3R2PIK3CA
SCHEMBL11867074 0.81 RAD52 (0.62) RAD52MAPTTHRBNFKB1NFKB2
SCHEMBL21625205 0.79 SHMT2 (0.42) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL21625053 0.77 NR1H4 (0.46) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL11859057 0.76 RAD52 (0.64) SHMT2RAD52POLBCCNA2CDK2
SCHEMBL21625207 0.76 SHMT2 (0.52) SHMT2PIK3CDPIK3R2PIK3CAPIK3CB
SCHEMBL11860266 0.76 RAD52 (0.58) RAD52NFKB1NFKB2RELAMALT1
Hydrochloric Acid SCHEMBL11865925 0.75 RAD52 (0.63) SHMT2RAD52POLBCCNA2CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020016315-A1 FUSED DIHYDROINDAZOLE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-23 — — WO claimed
WO-2020016315-A1 FUSED DIHYDROINDAZOLE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-23 — — WO disclosed
WO-2020016315-A1 FUSED DIHYDROINDAZOLE DERIVATIVES HAVING MULTIMODAL ACTIVITY AGAINST PAIN ESTEVE PHARMACEUTICALS, S.A. (ES) 2020-01-23 — — WO disclosed
Send feedback